(lp0
S'Research Brokerage Consensus Buys: AXT, Inc.  Xtant Medical ... Rives Journal - 14 hours ago Equity Research firms currently have a positive stance on shares of AXT, Inc. . The majority of analysts covering the equity have either a Buy or Strong Buy recommendation on the stock, yielding a consensus score of 1.80.Xtant Medical Holdings Inc  Given $2.75 Average Target Price by Analysts - Sports PerspectivesStock Price of Xtant Medical Holdings, Inc.  Increases 11.5% - Highland Mirror'
p1
aS'BRIEF-Xtant Medical Holdings Inc says Q4 loss per share $0.31 Reuters - Mar 9, 2017 BRIEF-Xtant Medical Holdings Inc says Q4 loss per share $0.31. March 9 Xtant Medical Holdings Inc : * Xtant Medical reports record fourth quarter revenue of $24.5 million, 10% growth compared to prior year period.'
p2
aS"Xtant Medical Holdings, Inc.  Files An 8-K Results of Operations ... Market Exclusive - Mar 9, 2017 The Company operates through the development, manufacture and marketing of regenerative medical products and devices segment.Xtant Medical Holdings'  CEO Carl O'Connell on Q4 2016 Results ... - Seeking AlphaConsensus Earnings Estimate for Xtant Medical Holdings, Inc. - Energy Index"
p3
aS'Investor Spotlight on Shares of Xtant Medical Holdings, Inc.  Baxter Review - 7 hours ago Individual investors might be studying multiple metrics in order to maximize returns. Xtant Medical Holdings, Inc.  presently has a Gross Margin  ratio of 0.432284.'
p4
aS"XTNT Announces Preliminary Fourth Quarter and Full Year 2016 Revenue ... GlobeNewswire  - Jan 11, 2017 BELGRADE, Mont., Jan. 11, 2017  -- Xtant Medical Holdings, Inc. , a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today has pre-announced&nbsp;...Xtant Medical reports preliminary Q4 and FY16 results - Seeking AlphaIs Xtant Medical Holdings Inc's  85% ROE Good Enough When Compared To ... - Simply Wall St"
p5
aS"Is Xtant Medical Holdings Inc's  ROE Of 85% Sustainable? Simply Wall St - Mar 9, 2017 Xtant Medical Holdings Inc's  ROE of 85% over the past year stood above the industry average of 15.24%. Often called the 'mother of all ratios', Return on Equity tells you how much capital is created in percentage terms for the amount ...Zacks: Analysts Set $2.83 Price Target for Xtant Medical Holdings Inc  - Petro Global News 24"
p6
aS"News Xtant Medical Holdings Inc.XTNT Wall Street Journal - Feb 11, 2011 News Xtant Medical Holdings Inc.XTNT. Significant News Only. 02/22/17; Press Release. Xtant Medical Announces Appointment of Carl O'Connell to Permanent CEO."
p7
aS"Xtant Medical Holdings  Appoints Carl O'Connell as Permanent CEO StreetInsider.com - Feb 22, 2017 Xtant Medical Holdings, Inc.  today announced the appointment of Carl O'Connell as the permanent CEO, effective February 17th, 2017."
p8
aS'Xtant Medical Holdings Announces Uplisting to NYSE MKT GlobeNewswire  - Oct 15, 2015 BELGRADE, Mont., Oct. 15, 2015  -- Xtant Medical Holdings, Inc. , a leader in the development of regenerative medicine products and medical devices, today announced that its common stock has been approved for listing on the&nbsp;...'
p9
aS"Xtant Medical Holdings'  CEO Dan Goldberger on Q3 2016 Results ... Seeking Alpha - Nov 8, 2016 My name is John Gandolfo, CFO of Xtant Medical. Thank you for joining us today for the Xtant Medical Holdings, Inc. third quarter 2016 results conference call."
p10
a.